Personalised medicine differs from precision medicine
Personalised medicine differs from precision medicine
Approaches to screening and early detection across Europe
Connecting personalised medicine research in Canada with Europe
Roche joining forces to forward precision oncology
Shortening the time to manufacture CAR T-cells
Long term follow up on the ZUMA-1 trial for nHL
SABCS 2017: The latest in CDK inhibition in breast cancer
Autologous haematopoietic cell transplant for mantle cell lymphoma
Dexamethasone and the UKALL 2011 trial
Circulating tumour cells may predict late recurrence in HR-positive breast cancer patients
Postmenopausal women who lose weight may have reduced breast cancer risk
Talazoparib vs physicians choice for patients with mBRCA1 breast cancer